A detailed history of Manufacturers Life Insurance Company, The transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 114,757 shares of KYMR stock, worth $3.43 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
114,757
Previous 100,073 14.67%
Holding current value
$3.43 Million
Previous $2.55 Million 81.12%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$22.9 - $43.57 $336,263 - $639,781
14,684 Added 14.67%
114,757 $4.61 Million
Q4 2023

Feb 13, 2024

BUY
$10.97 - $26.84 $253,330 - $619,816
23,093 Added 30.0%
100,073 $2.55 Million
Q3 2023

Nov 15, 2023

SELL
$13.9 - $23.88 $61,299 - $105,310
-4,410 Reduced 5.42%
76,980 $1.07 Million
Q2 2023

Aug 11, 2023

BUY
$22.4 - $34.92 $367,449 - $572,827
16,404 Added 25.24%
81,390 $1.87 Million
Q1 2023

May 15, 2023

BUY
$24.84 - $38.75 $272,122 - $424,506
10,955 Added 16.86%
75,941 $2.25 Million
Q4 2022

Aug 11, 2023

SELL
$19.57 - $30.92 $2,407 - $3,803
-123 Reduced 0.19%
64,986 $1.62 Million
Q4 2022

Feb 13, 2023

SELL
$19.57 - $30.92 $2,407 - $3,803
-123 Reduced 0.19%
64,986 $1.62 Million
Q3 2022

Aug 11, 2023

SELL
$20.91 - $34.27 $14,971 - $24,537
-716 Reduced 1.09%
65,109 $1.42 Million
Q3 2022

Nov 03, 2022

SELL
$20.91 - $34.27 $14,971 - $24,537
-716 Reduced 1.09%
65,109 $1.43 Million
Q2 2022

Aug 11, 2023

BUY
$14.13 - $42.55 $62,341 - $187,730
4,412 Added 7.18%
65,825 $1.3 Million
Q2 2022

Aug 15, 2022

BUY
$14.13 - $42.55 $62,341 - $187,730
4,412 Added 7.18%
65,825 $1.33 Million
Q1 2022

Aug 11, 2023

SELL
$35.3 - $64.68 $512,838 - $939,671
-14,528 Reduced 19.13%
61,413 $2.6 Million
Q1 2022

May 20, 2022

BUY
$35.3 - $64.68 $1.54 Million - $2.82 Million
43,674 Added 246.2%
61,413 $2.56 Million
Q4 2021

Feb 16, 2022

BUY
$49.91 - $65.56 $21,111 - $27,731
423 Added 2.44%
17,739 $1.12 Million
Q3 2021

Nov 12, 2021

BUY
$47.8 - $66.66 $55,017 - $76,725
1,151 Added 7.12%
17,316 $1.02 Million
Q2 2021

Aug 12, 2021

BUY
$31.08 - $51.95 $312,385 - $522,149
10,051 Added 164.39%
16,165 $784,000
Q1 2021

May 03, 2021

BUY
$35.64 - $85.46 $1,746 - $4,187
49 Added 0.81%
6,114 $238,000
Q4 2020

Feb 12, 2021

BUY
$28.07 - $87.83 $170,244 - $532,688
6,065 New
6,065 $376,000

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $1.63B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Manufacturers Life Insurance Company, The Portfolio

Follow Manufacturers Life Insurance Company, The and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.